Adams was born in Byfield, Northamptonshire, at 4 New Terrace (later re-numbered as no. 7) on 16 April 1923.[2][3] His father was a railwayman, and grew up in a rural farming area in Northamptonshire.[4] Adams was an only child.
At the Boots Pure Drug Company in 1953, Adams began work on other chemical substances that could have a pain-killing effect, centred on rheumatoid arthritis. He worked in a house in the south of Nottingham for many years, as the main labs had been destroyed in the war, then moved to Boots Pharmaceuticals new building on Pennyfoot Street in 1960 where there was a radioactive lab. This is now BioCity Nottingham.
Four substances that went to clinical trial failed, and the last – ibuprofen – worked; it was first called RD 13621, and RB 1472. He took the first dose himself and used the drug to treat his own headaches before it was on the market. Animal tests were very encouraging, and tests on humans showed it was about three times stronger than aspirin. He had read in a German journal about ultra-violet-induced erythema on the skin of shaved guinea pigs discovered by Parke-Davis, so he could test anti-inflammatory treatments; the UV-light came from a Kromayer Lamp. Some drugs had had amazing effects on albino guinea pigs, but none on humans. It had low GI toxicity in dogs. Boots also now wanted the new chemical to reduce fever (an antipyretic effect). The work was supported in the 1950s by the Empire Rheumatism Council (now Arthritis Research UK). The first clinical trials were by Dr. Tom Chalmers at the Rheumatic Diseases Unit at the Northern General Hospital, Edinburgh (which closed around 1990) in 1966.
Licensing
A patent was filed in 1962, and granted in 1962, for phenylalkane derivatives. In 1969 ibuprofen was licensed as a prescription drug in the UK, and in 1974 in the US. It was launched in the US in 1974 by Upjohn of Kalamazoo, Michigan, as Motrin. In April 1966, Ibufenac (iso-butyl-phenyl-acetic-acid, known as Dytransin) went onto the UK market, but was withdrawn in January 1968 due to causing jaundice, from its toxicity in the liver.[14]
General pharmacies
In August 1978, Boots applied to have ibuprofen put in general pharmacies, but the Committee on Safety of Medicines (DHSS) declined; in April 1982, there was another request by Boots. Ibuprofen became on sale for general pharmacy (over-the-counter) in 1983, as Nurofen.[15] Adams said in 2007 "Getting the drug approved by the two countries with the toughest regulatory authorities – the UK and the US – was a goal I wanted to achieve. For me, that was the most exciting time of all."[4] Nurofen was launched 8 August 1983 by Crookes Products Ltd. Ibuprofen went over the counter in the US in June 1984 by the Food and Drug Administration, made by American Home Products. In America, it was made by Whitehall Laboratories, known as Advil, and also sold as Nuprin.[16]
In November 2013 work on ibuprofen was recognised by the erection of a Royal Society of Chemistry blue plaque at Boots' Beeston Factory site in Nottingham, which reads:[19]
In recognition of the work during the 1980s by The Boots Company PLC on the development of ibuprofen which resulted in its move from prescription only status to over the counter sale, therefore expanding its use to millions of people worldwide
and another at BioCity Nottingham, the site of the original laboratory, which reads:[19]
In recognition of the pioneering research work, here on Pennyfood Street, by Dr Stewart Adams and Dr John Nicholson in the Research Department of Boots which led to the discovery of ibuprofen used by millions worldwide for the relief of pain.
Dr Stewart Adams Bridge
A new pedestrian and cycle bridge connecting the Nottingham Science Park to the Boots head office campus, over the Midland Main Line, was named after Adams, as part of the electrification works.[20]
